And we further found that TAZ showed high expression in ccRCC and patients with high TAZ expression had a lower overall survival rate (Figures 5(b)–5(d)), which was consistent with MITD1. This evidence concerns the gene WWTR1 and nonpapillary renal cell carcinoma.